17 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
, Massachusetts, both regions that are headquarters to many other pharmaceutical companies and many academic and research institutions. Competition for skilled
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
. Competition for skilled personnel is intense and the turnover rate can be high, which may limit our ability to hire and retain
highly qualified personnel
424B4
g2hhb
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
tijclq81 qt5zafg9
2 Jun 21
Draft registration statement
12:00am
10-K
a7l8k p4qf
31 Mar 21
Annual report
2:14pm
424B4
smgbpiw5qhh
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
szqusuoq2j522
23 Jul 20
IPO registration
12:28pm
DRS/A
tf8p sots4n
16 Oct 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next